GBT
Global Blood Therapeutics Inc.

3,909
Loading...
Loading...
Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Global Blood Therapeutics Inc.?
What is the 52-week high for Global Blood Therapeutics Inc.?
What is the 52-week low for Global Blood Therapeutics Inc.?
What is Global Blood Therapeutics Inc. stock price today?
What was Global Blood Therapeutics Inc. stock price yesterday?
What is the PE ratio of Global Blood Therapeutics Inc.?
What is the Price-to-Book ratio of Global Blood Therapeutics Inc.?
What is the 50-day moving average of Global Blood Therapeutics Inc.?

Latest GBT News

View
No GBT news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.